(1)
Gimbel, MD, J. S.; Rauck, MD, R. L.; Bass, PharmD, A.; Wilson, PharmD, J.; Pixton, MS, G.; Malhotra, PhD, B.; Wilson PhD, G.; Wolfram, MD, G. Effects of Naltrexone Exposure Observed in Two Phase Three Studies With ALO-02, an Extended-Release Oxycodone Surrounding Sequestered Naltrexone. J of Opioid Management 2019, 15, 417-427.